TIME TITLE SPEAKER 8:00–8:30 Networking, Registration   8:30–8:35 Opening Speech Shidong Jia (Predicine) Session 1 China for Global: Biomarker & CDx Solutions for Clinical Trials  Chair: Chunxia Su (Shanghai Pulmonary Hospital) 8:35–8:55 Integrated molecular analysis of NSCLC brain metastasis tissue and multimodal ctDNA reveals distinct signatures of patient outcomes Darin Dolezel (Yale) 8:55–9:15 Advancing NMIBC...

   

   

Conference Presentation Title: Transforming Global Clinical Trials with Liquid Biopsy and CDx Solutions Date: August, 2021 Duration: 16 minutes Predicine’s Founder and CEO, Dr. Shidong Jia, recently presented at the Next Generation Dx Summit in Washington D.C. During Dr. Jia’s talk Transforming Global Clinical Trials with Liquid Biopsy and CDx Solutions  he highlighted several recent...

Webinar title: Liquid-based Detection of Copy Number Variations (CNVs) in Cancer Date: Wednesday, April 6, 2021 Duration: 32 minutes The liquid biopsy landscape (CNVs) is changing rapidly. Predicine is advancing the clinical utility of liquid biopsy more broadly across the continuum of cancer care. We are innovating our liquid biopsy technology to detect a range of...

Webinar title: Liquid-based Detection of Copy Number Variations (CNVs) in Cancer Date: Tuesday, April 6, 2021 Duration: 40 minutes Copy number variations (CNVs) are often correlated with negative outcomes for cancer patients, however they are challenging to detect in liquid biopsy samples. Improvements in next generation sequencing (NGS) technology is enhancing the possibility of detecting these deleterious...